Termination of Inducement Stock Option
Contract Categories:
Business Finance
- Stock Agreements
EX-10.168.1 2 a05-11288_1ex10d168d1.htm EX-10.168.1
Exhibit 10.168.1
Termination of Inducement Stock Option
Reference is made to that certain option to purchase 750,000 shares of Common Stock of The Immune Response Corporation (the “Company”) that was granted to Robert E. Knowling, Jr. (“Knowling”) pursuant to the Inducement Stock Option Grant Notice dated February 9, 2005 (the “Option”).
The Company and Knowling agree that the Option is hereby terminated, effective immediately.
Dated: June 22, 2005
|
| The Immune Response Corporation | ||||
|
|
| ||||
|
| By: | /s/ Michael K. Green |
| ||
|
|
| Michael K. Green | |||
|
|
| Vice President, Finance and Chief Financial | |||
|
|
| ||||
|
|
| ||||
|
| /s/ Robert E. Knowling, Jr. |
| |||
|
| Robert E. Knowling, Jr. | ||||
